healthcare professional for medical advice
cytokine release syndrome
difficult urination
retreatment with muromonab cd
lymphoproliferative disorder
datum
pulmonary edema
muromonab cd
bronchospasm
feel thing
black tarry stool
ulcer
pretreatment period
cranial nerve palsy
cardiovascular
fever and chill
cardiovascular collapse
recent myocardial infarction
delay renal graft function
rash
symptom of fever
majority of lymphoma
complement activation
lymphopenia
mortality
development of new malignancy
photophobia
dizziness or faintness
apnea
blood urea nitrogen
tinnitus
diastolic blood pressure
weakness
arrhythmia
stiff neck
malaise
vomit
seizure
reduce left ventricular compliance
wheeze
lymphoma
double vision
nausea
mmhg
other vascular bed
negative culture
skin rash
shake of hand
shock
intragraft thrombose
benefit
eosinophilia
risk of neoplastic disease
unusual sensitivity of eye
thrombosis of allograft
vision
control group
von willebrand
tightness in the chest
cytomegalovirus
degree fahrenheit
significant intervention
t cell
result of immunosuppression
see
angioedema
elevated protein
angina
troubled breathing
anti mouse antibody titer
interleukin
bruise
additional risk factor
b cell lymphoma
cause glomerulonephritis
septic shock
thrombocytopenia
encounter infection during muromonab cd
heart failure
stool
fungal infection
depletion
conjunctivitis
ventricular dysfunction
vertigo
other infection
disturbance in coagulation
interstitial nephritis
hearing
be find
permanent neurologic deficit
blood in urine
nuchal rigidity
orthoclone okt
loss of hearing
confusion
tremble
acute clinical syndrome
increase pulmonary vascular permeability
role in the thrombotic event
joint pain
coma
murine derive product
respiratory arrest
change
heparin
reversible renal dysfunction
pancytopenia
cytokine encephalopathy
unusual tiredness
pruritus
severity of symptom
elevation in prothrombin fragment
more serious sequela
mouth
itch or tingle
experimental anti tnf monoclonal antibody
contractility
vi
pancreatitis
use of muromonab cd
pulmonary sequestration
activate t cell
general feeling of discomfort
active ingredient
red spot on skin
respiratory distress syndrome
cytokine nephropathy
case of bowel infarction
pentoxifylline
cr
convulsion seizure
abnormal urinalysis
dyspnea
light
cerebrovascular disease
gamma interferon
addition
severe case
unstable angina
spike
symptomatic ischemic heart disease
tachycardia
severe require fluid management
headache
benign polyclonal b cell hyperplasia
activate granulocyte
nausea vomiting
thrombotic event within main graft vessel
pleocytosis
month
factor
nausea and vomit
hemodynamic instability
severe hypotension
history of seizure
sore
cardiac arrest
protozoal
manifestation
way that muromonab cd act on the body
blindness
oliguria
tumor necrosis factor
other agent
swell of face
chill
fda
leukopenia
medical attention
hypotension
transplantation
cerebral spinal fluid finding
aseptic meningitis
cough or hoarseness
myalgia
hallucination
uncompensated heart failure
herpes simplex
caution
skin cancer
anaphylaxis
illness
occurrence of pulmonary edema
temporal arteritis
significant increase in morbidity
obtundation
encephalopathy
leukocytosis
general
anuria
throat
hypertension
mental status change
aplastic anemia
heart rate
intravascular volume overload
slight decline in renal function
certain type of cancer
transient increase in serum creatinine
hearing loss
immune complex deposition
endothelial cell activation
vasculitis
diarrhea
mechanism
serum creatinine
cerebritis
neutropenia
unusual bleeding
tumor necrosis factor alpha
nervous system
tachypnea
conflict
irregular heartbeat
play
fever
increase risk of invasive cytomegalovirus infection in recipient of cmv positive graft
side pain
serum sickness
lymphadenopathy
anterior scleritis
respiratory failure
diastolic pressure
chance
elevated prothrombin fragment
rigor
infection
significant change in blood pressure
mediator of muromonab cd induce coagulopathy
painful gland
volume
release of cytokine
shortness of breath
concern
arthralgia
white spot on the lip
increase in blood pressure
chest pain
graft vessel thrombose
granulocyte colony stimulating factor
muscle
indomethacin
bradycardia